Home/LungLife AI/David Anderson
DA

David Anderson

Chief Financial Officer

LungLife AI

Therapeutic Areas

LungLife AI Pipeline

DrugIndicationPhase
LungLB® TestEvaluation of indeterminate lung nodules for lung cancer riskCommercial (LDT)